Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Efficacy and Safety of Ferric Citrate Tablet for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NCT04456803 is registered in ClinicalTrials.gov with Sinomune Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT04456803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04456803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Efficacy and Safety of Ferric Citrate Tablet for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Lead sponsor
Sinomune Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
May 24, 2019
Completion date
September 13, 2022
Enrollment
239 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, esrd, hyperphosphatemia